Literature DB >> 30126925

Functional interplay between c-Myc and Max in B lymphocyte differentiation.

Mercedes Pérez-Olivares1, Alfonsina Trento1, Sara Rodriguez-Acebes2, Daniel González-Acosta2, David Fernández-Antorán1, Sara Román-García1, Dolores Martinez2, Tania López-Briones2, Carlos Torroja3, Yolanda R Carrasco1, Juan Méndez2, Ignacio Moreno de Alborán4.   

Abstract

The Myc family of oncogenic transcription factors regulates myriad cellular functions. Myc proteins contain a basic region/helix-loop-helix/leucine zipper domain that mediates DNA binding and heterodimerization with its partner Max. Among the Myc proteins, c-Myc is the most widely expressed and relevant in primary B lymphocytes. There is evidence suggesting that c-Myc can perform some of its functions in the absence of Max in different cellular contexts. However, the functional in vivo interplay between c-Myc and Max during B lymphocyte differentiation is not well understood. Using in vivo and ex vivo models, we show that while c-Myc requires Max in primary B lymphocytes, several key biological processes, such as cell differentiation and DNA replication, can initially progress without the formation of c-Myc/Max heterodimers. We also describe that B lymphocytes lacking Myc, Max, or both show upregulation of signaling pathways associated with the B-cell receptor. These data suggest that c-Myc/Max heterodimers are not essential for the initiation of a subset of important biological processes in B lymphocytes, but are required for fine-tuning the initial response after activation.
© 2018 The Authors.

Entities:  

Keywords:  B lymphocytes; Max; cell differentiation; c‐Myc; replication

Mesh:

Substances:

Year:  2018        PMID: 30126925      PMCID: PMC6172472          DOI: 10.15252/embr.201845770

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  63 in total

Review 1.  MAP Kinase Cascades in Antigen Receptor Signaling and Physiology.

Authors:  Tomoharu Yasuda
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

2.  Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.

Authors:  R C Rickert; K Rajewsky; J Roes
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

3.  Bin1 mediates apoptosis by c-Myc in transformed primary cells.

Authors:  J B DuHadaway; D Sakamuro; D L Ewert; G C Prendergast
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 4.  Transcriptional control of pre-B cell development and leukemia prevention.

Authors:  Swee Heng Milon Pang; Sebastian Carotta; Stephen L Nutt
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

5.  c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.

Authors:  José P Vaqué; Belén Fernández-García; Pablo García-Sanz; Nuria Ferrandiz; Gabriel Bretones; Fernando Calvo; Piero Crespo; María C Marín; Javier León
Journal:  Mol Cancer Res       Date:  2008-02       Impact factor: 5.852

Review 6.  Myc and cell cycle control.

Authors:  Gabriel Bretones; M Dolores Delgado; Javier León
Journal:  Biochim Biophys Acta       Date:  2014-04-01

7.  The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

8.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  The human GINS complex associates with Cdc45 and MCM and is essential for DNA replication.

Authors:  Tomás Aparicio; Emmanuelle Guillou; Javier Coloma; Guillermo Montoya; Juan Méndez
Journal:  Nucleic Acids Res       Date:  2009-02-17       Impact factor: 16.971

View more
  6 in total

1.  An early Myc-dependent transcriptional program orchestrates cell growth during B-cell activation.

Authors:  Alessandra Tesi; Stefano de Pretis; Mattia Furlan; Marco Filipuzzi; Marco J Morelli; Adrian Andronache; Mirko Doni; Alessandro Verrecchia; Mattia Pelizzola; Bruno Amati; Arianna Sabò
Journal:  EMBO Rep       Date:  2019-07-23       Impact factor: 8.807

2.  An IRF4-MYC-mTORC1 Integrated Pathway Controls Cell Growth and the Proliferative Capacity of Activated B Cells during B Cell Differentiation In Vivo.

Authors:  Dillon G Patterson; Anna K Kania; Madeline J Price; James R Rose; Christopher D Scharer; Jeremy M Boss
Journal:  J Immunol       Date:  2021-09-01       Impact factor: 5.426

3.  BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer.

Authors:  Ran Zhao; Yukun Liu; Chunchun Wu; Mengna Li; Yanmei Wei; Weihong Niu; Jing Yang; Songqing Fan; Yong Xie; Hui Li; Wei Wang; Zhaoyang Zeng; Wei Xiong; Xiaoling Li; Guiyuan Li; Ming Zhou
Journal:  Front Cell Dev Biol       Date:  2021-05-24

Review 4.  Epigenetic gene regulation in plasma cells.

Authors:  Dillon G Patterson; Anna K Kania; Zhihong Zuo; Christopher D Scharer; Jeremy M Boss
Journal:  Immunol Rev       Date:  2021-05-19       Impact factor: 10.983

5.  Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis.

Authors:  Haritha Mathsyaraja; Brian Freie; Pei-Feng Cheng; Ekaterina Babaeva; Jonathen T Catchpole; Derek Janssens; Steven Henikoff; Robert N Eisenman
Journal:  Genes Dev       Date:  2019-08-08       Impact factor: 11.361

6.  Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer.

Authors:  Zhaoliang Yu; Peng Deng; Yufeng Chen; Shini Liu; Jinghong Chen; Zihuan Yang; Jianfeng Chen; Xinjuan Fan; Peili Wang; Zerong Cai; Yali Wang; Peishan Hu; Dezheng Lin; Rong Xiao; Yifeng Zou; Yan Huang; Qiang Yu; Ping Lan; Jing Tan; Xiaojian Wu
Journal:  Adv Sci (Weinh)       Date:  2021-10-28       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.